This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Gai Yan: Innovator in Cancer Therapy
Introduction
Gai Yan is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer therapy through his innovative research and patents. His work focuses on the use of histone acetyltransferase inhibitors as novel anti-cancer therapies.
Latest Patents
Gai Yan holds a patent titled "Use of histone acetyltransferase inhibitors as novel anti-cancer therapies." This invention provides methods for treating cancer by inhibiting the activity of p300/CBP histone acetyltransferase (HAT). The patent also includes p300/CBP HAT inhibitors for treating subjects with cancer. Additionally, it introduces biomarkers for p300/CBP HAT inhibition, which are utilized to monitor the effectiveness of cancer therapy and identify anti-cancer agents for use in combination therapy. Gai Yan has 1 patent to his name.
Career Highlights
Gai Yan is affiliated with Johns Hopkins University, where he conducts his research and develops his innovative therapies. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Gai Yan collaborates with esteemed colleagues, including Rhoda Myra Alani and Philip A Cole. Their combined expertise enhances the research and development of effective cancer therapies.
Conclusion
Gai Yan's contributions to cancer therapy through his innovative patent demonstrate his commitment to advancing medical science. His work at Johns Hopkins University continues to pave the way for new treatment options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile